inflammatory disease
| 3 min read
A team from Stanford and NYU shows how Bacteroides fragilis can activate pain pathways, revealing a new microbial culprit in digestive disease.
| 2 min read
First DPP1 inhibitor drug milestone marks a long-awaited breakthrough for NCFB patients.
| 3 min read
The deal reflects growing interest in covalent chemistry as a solution for “undruggable” inflammatory proteins.
| 2 min read
Breakthrough data validates capabilities of GlueSEEKER platform to identify novel induced protein-protein interactions and expand druggable space
| 4 min read
Researchers developed a PET probe that targets all immune cells to help diagnose and monitor inflammatory diseases.
| 4 min read
Microparticle injections containing an immunomodulator protein inhibited bone loss and promoted repair in a mouse model of periodontal disease.
| 6 min read
Researchers use cell-free DNA circulating in the blood of patients with rheumatoid arthritis to match them with the most effective drugs.
| 3 min read
Exercising lab-grown human muscle can block the effects of interferon gamma
| 2 min read
Data supporting Applied Molecular Transport's AMT-101 in treating inflammatory diseases published in The Journal of Immunology
Page 1 of 1 - 9 Total Items
